Search
Search
About
Log in
Join
Experiences with
Triple bromide
Posts
Communities
5,255 public posts
Filter results
Possible Upcoming Parkinson's Disease Clinical Trial in Q1 2022
https://www.clinicaltrialsarena.com/analysis/annovis-alzheimers-parkinsons/ Link to article about possible upcoming Phase III clinical trial for Parkinson's Disease sponsored by Pennsylvania based biotech - Annovis. Here is a blurb from the article: "Both trials [they are also doing an Alzheimer's trial
https://www.clinicaltrialsarena.com/analysis/annovis-alzheimers-parkinsons/ Link to article about possible upcoming Phase III clinical trial for Parkinson's Disease sponsored by Pennsylvania based biotech - Annovis. Here is a blurb from the article: "Both trials [they are also doing an Alzheimer's trial
Canddy
in
Cure Parkinson's
3 years ago
Clinical Trial Update
I wanted to give this forum an update on my participation in the clinical trial at the University of Texas in Houston. I was reluctant to comment before the study was completed but was compelled by my wife to do so. It has been nearly one month since my first infusion, but my family has witnessed some
I wanted to give this forum an update on my participation in the clinical trial at the University of Texas in Houston. I was reluctant to comment before the study was completed but was compelled by my wife to do so. It has been nearly one month since my first infusion, but my family has witnessed some
PrayN4aCure
in
Cure Parkinson's
3 years ago
Does anything go right
Now the clinical trial is saying they don’t take our ins. For labs the consult. Bone scans. I wish we knew this we had our hopes so high only for another let down. The consult alone is quite a bit,
Now the clinical trial is saying they don’t take our ins. For labs the consult. Bone scans. I wish we knew this we had our hopes so high only for another let down. The consult alone is quite a bit,
Fight11
in
Advanced Prostate Cancer
3 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Neuroendocrine Prostate Cancer [NEPC]
New review below [1]. (The link is to the full text.) "With wide availability of potent androgen receptor targeted agents (ARTAs), the incidence of
[i]treatment-related[/i]
neuroendocrine prostate cancer (t-NEPC) has been dramatically increasing." "Clinically, NEPC is grossly classified based
New review below [1]. (The link is to the full text.) "With wide availability of potent androgen receptor targeted agents (ARTAs), the incidence of
[i]treatment-related[/i]
neuroendocrine prostate cancer (t-NEPC) has been dramatically increasing." "Clinically, NEPC is grossly classified based
pjoshea13
in
Advanced Prostate Cancer
3 years ago
Clinical trial
I really could use some advice please and thank you. My husband has been approved for a clinical trial at Cornell. The project number is 20-08022486. It would involve quite a bit of travel which we will do if need be. Another concern is the trial start date is mid Dec. He was suppose to start his chemo
I really could use some advice please and thank you. My husband has been approved for a clinical trial at Cornell. The project number is 20-08022486. It would involve quite a bit of travel which we will do if need be. Another concern is the trial start date is mid Dec. He was suppose to start his chemo
Fight11
in
Advanced Prostate Cancer
3 years ago
Update
I’m getting released today from the hospital. I had my defibrillator wire removed this past Wednesday. A very delicate procedure considering the wire has been in for 17 years. The wire has damaged my Tricuspid valve in my heart allowing blood to back up into my liver and cause cardiac cirrhosis. Hopefully
I’m getting released today from the hospital. I had my defibrillator wire removed this past Wednesday. A very delicate procedure considering the wire has been in for 17 years. The wire has damaged my Tricuspid valve in my heart allowing blood to back up into my liver and cause cardiac cirrhosis. Hopefully
Bluegirl52
in
Living with Fatty Liver and NASH
3 years ago
immunostimulant / bacterial lysate tablets?
I've recently learnt about "immunostimulant tablets" and I was wondering if this is anything for people with CLL. I won't give any brand names, but in principle, they contain "Bacterial Lysate" (dead, broken down bacteria), in form of a tablet, for example: Staphylococcus aureus Streptococcus pyogenes
I've recently learnt about "immunostimulant tablets" and I was wondering if this is anything for people with CLL. I won't give any brand names, but in principle, they contain "Bacterial Lysate" (dead, broken down bacteria), in form of a tablet, for example: Staphylococcus aureus Streptococcus pyogenes
mantana
in
CLL Support
3 years ago
Eight weeks into hospice. Strange experience.
I suppose I never had a great understanding of what hospice was all about. Just a short background. Prostate cancer for 18 years, approx 13 years at stage four. No surgery, instead 40+ rounds of radiation, Lupron, casodex, aberiteron, enzalutamide, three clinical trials, don’t remember how many rounds
I suppose I never had a great understanding of what hospice was all about. Just a short background. Prostate cancer for 18 years, approx 13 years at stage four. No surgery, instead 40+ rounds of radiation, Lupron, casodex, aberiteron, enzalutamide, three clinical trials, don’t remember how many rounds
JimBarringer
in
Advanced Prostate Cancer
3 years ago
LLS (USA) Answers to COVID-19 questions based on trials with CLL and NHL patients in USA
The LLS clinical trials have yielded excellent data regarding the experience of 7000 Lymphoma patients. Here are links to the most recent 2 Videos. https://youtu.be/4WSXqs73Wjk ASK AN EXPERT: EPISODE 6 (11.12.2021) Dr. Larry Saltzman, Executive Research Director at LLS, answers the following questions
The LLS clinical trials have yielded excellent data regarding the experience of 7000 Lymphoma patients. Here are links to the most recent 2 Videos. https://youtu.be/4WSXqs73Wjk ASK AN EXPERT: EPISODE 6 (11.12.2021) Dr. Larry Saltzman, Executive Research Director at LLS, answers the following questions
lankisterguy
Volunteer
in
CLL Support
3 years ago
anyone participated in Freedom-1?
I'm getting ready for my transplant. people from FREEDOM-1 trial reached out and ask to see if I'm interested in their clinical trial. it sounds promising. are there anyone who has participated? it sounds like a great solution to the anti- rejection medications.
I'm getting ready for my transplant. people from FREEDOM-1 trial reached out and ask to see if I'm interested in their clinical trial. it sounds promising. are there anyone who has participated? it sounds like a great solution to the anti- rejection medications.
sanrioche
in
Kidney Transplant
3 years ago
Misc Promising Research
============ INPUT #2 From a friend directing scientific research on stem cells [not aimed at Parkinson's] at Stanford, in response to INPUT #1 below from another friend [not suffering from Parkinson's]: ======================== Okay, i have some information. some of it encouraging, other information
============ INPUT #2 From a friend directing scientific research on stem cells [not aimed at Parkinson's] at Stanford, in response to INPUT #1 below from another friend [not suffering from Parkinson's]: ======================== Okay, i have some information. some of it encouraging, other information
Pa-zzi69
in
Cure Parkinson's
3 years ago
Yumanity Therapeutics successfully completes its Phase 1b trial of YTX-7739
"Yumanity Therapeutics announced that its investigational therapy, YTX-7739, worked to safely inhibit stearoyl-CoA desaturase — an enzyme thought to play a role in the alpha-synuclein-derived toxicity seen in Parkinson’s — in a Phase 1b clinical trial in people with mild-to-moderate disease." https:
"Yumanity Therapeutics announced that its investigational therapy, YTX-7739, worked to safely inhibit stearoyl-CoA desaturase — an enzyme thought to play a role in the alpha-synuclein-derived toxicity seen in Parkinson’s — in a Phase 1b clinical trial in people with mild-to-moderate disease." https:
jeffreyn
in
Cure Parkinson's
3 years ago
HSV-infections
The most common drugs for treating HSV-infections are antivirals, such as acyclovir, valacyclovir and famciclovir. But what are the options if these common treatments do not help during a relapse? A clinical trial for a new drug called PRITELIVIR is now entering Phase 3. This drug has passed all previous
The most common drugs for treating HSV-infections are antivirals, such as acyclovir, valacyclovir and famciclovir. But what are the options if these common treatments do not help during a relapse? A clinical trial for a new drug called PRITELIVIR is now entering Phase 3. This drug has passed all previous
Helene77
in
My MSAA Community
3 years ago
ErSO update
Hi wonderful people, Many of you asked to post the update. Here is the update posted on Facebook in “ErSO activism for breast cancer” Hello Friends, We thought we would post an update from the admins of the page with what we currently know about the status of ErSO. As best we can tell we still believe
Hi wonderful people, Many of you asked to post the update. Here is the update posted on Facebook in “ErSO activism for breast cancer” Hello Friends, We thought we would post an update from the admins of the page with what we currently know about the status of ErSO. As best we can tell we still believe
Cureforever
in
SHARE Metastatic Breast Cancer
3 years ago
Still they don't get it
Thiis review yet again commits the cardinal sin of lumping in together the majority who are indifferent to T4 only therapy, and those who benefit from combination. Another useless waste of paper with as usual, the allegation that T4 only and T4/T3 therapy are no different (though a minority preferred
Thiis review yet again commits the cardinal sin of lumping in together the majority who are indifferent to T4 only therapy, and those who benefit from combination. Another useless waste of paper with as usual, the allegation that T4 only and T4/T3 therapy are no different (though a minority preferred
diogenes
in
Thyroid UK
3 years ago
Webinar 3.30pm 12th November - CAR-T therapy update
Today 3.30pm - free spaces available Want to learn more about the current UK status of CAR-T therapy? Join our webinar where our expert panel will explain how the therapy works, what is involved and how it is used to treat leukaemia. You can register here: https://t.co/0C0mu1r3Ds?amp=1 We will be joined
Today 3.30pm - free spaces available Want to learn more about the current UK status of CAR-T therapy? Join our webinar where our expert panel will explain how the therapy works, what is involved and how it is used to treat leukaemia. You can register here: https://t.co/0C0mu1r3Ds?amp=1 We will be joined
HAIRBEAR_UK
in
Leukaemia Support
3 years ago
Global Liver Institute’s meeting yesterday benefits everyone.......
I believe we all received via email a link to yesterday’s meeting. Thank You Wayne for providing the link. For me it was time well spent. I did not know that the FDA had, in 2020 I believe, created a Division of Hepatology. The meeting provided the opportunity for several NASH patients, and patient
I believe we all received via email a link to yesterday’s meeting. Thank You Wayne for providing the link. For me it was time well spent. I did not know that the FDA had, in 2020 I believe, created a Division of Hepatology. The meeting provided the opportunity for several NASH patients, and patient
Troutwhisperer
in
Living with Fatty Liver and NASH
3 years ago
Dasatinib
I was interested to see in the latest from the Mayo: "
Antidiabetic Effects of the Senolytic Agent Dasatinib
" [1] Many men with PCa are pre-diabetic at diagnosis, with some of the symptons of the metabolic syndrome [MetS]. Pre-diabetics do not necessarily progress to diabetes, but androgen deprivation
I was interested to see in the latest from the Mayo: "
Antidiabetic Effects of the Senolytic Agent Dasatinib
" [1] Many men with PCa are pre-diabetic at diagnosis, with some of the symptons of the metabolic syndrome [MetS]. Pre-diabetics do not necessarily progress to diabetes, but androgen deprivation
pjoshea13
in
Advanced Prostate Cancer
3 years ago
Rising PSA after chemo, next steps?
My husband, 67, was Dx with high volume aggressive metastatic PC in April. PSA was 72.8. Started degarelix, had 6 sessions of docetaxel, added abiraterone in August, consolidative SBRT in September. Lowest PSA was 0.99 right after chemo, in August. In September, 1.12, October 1.87, and now in November
My husband, 67, was Dx with high volume aggressive metastatic PC in April. PSA was 72.8. Started degarelix, had 6 sessions of docetaxel, added abiraterone in August, consolidative SBRT in September. Lowest PSA was 0.99 right after chemo, in August. In September, 1.12, October 1.87, and now in November
leebeth
in
Advanced Prostate Cancer
3 years ago
Phase 1 clinical trial: CST-103 Improves Brain Blood Flow in Early Clinical Trial (Phase 2 enrolling)
Treatment with the investigational therapy CST-103 increased blood flow to certain regions of the brains of people with Parkinson’s disease and mild cognitive impairment, results of a small clinical trial show. The type of increased blood flow that was seen “correlates with increased neuronal activity
Treatment with the investigational therapy CST-103 increased blood flow to certain regions of the brains of people with Parkinson’s disease and mild cognitive impairment, results of a small clinical trial show. The type of increased blood flow that was seen “correlates with increased neuronal activity
Hidden
in
Cure Parkinson's
3 years ago
1
...
71
72
73
...
100
Next page
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
1311 results
Cure Parkinson's
658 results
CLL Support
628 results
View top 10 communities
Sort by
Most Relevant
Newest